Exploratory analyses incorporating CRP and lipid measures argued against major confounding in controls and MCI, however, unrecorded variables such as body-mass index, metabolic syndrome, diabetes, or hypertension could have contributed to variability in peripheral CHI3L1 expression. This evidence concerns the gene CHI3L1 and metabolic syndrome.